Abstract. It is widely accepted that cervical screening has significantly reduced the incidence of cervical cancer worldwide. The primary screening test for cervical cancer is the Papanicolaou (Pap) test, which has extremely variable specificity and sensitivity. There is an unmet clinical need for methods to aid clinicians in the early detection of cervical precancer. Raman spectroscopy is a label-free objective method that can provide a biochemical fingerprint of a given sample. Compared with studies on infrared spectroscopy, relatively few Raman spectroscopy studies have been carried out to date on cervical cytology. The aim of this study was to define the Raman spectral signatures of cervical exfoliated cells present in liquid-based cytology Pap test specimens and to compare the signature of high-grade dysplastic cells to each of the normal cell types. Raman spectra were recorded from single exfoliated cells and subjected to multivariate statistical analysis. The study demonstrated that Raman spectroscopy can identify biochemical signatures associated with the most common cell types seen in liquid-based cytology samples; superficial, intermediate, and parabasal cells. In addition, biochemical changes associated with high-grade dysplasia could be identified suggesting that Raman spectroscopy could be used to aid current cervical screening tests.
Introduction
Cervical cancer is the fourth most common malignancy among women worldwide, with an estimated 528,000 cases diagnosed in 2012. Of these, 266,000 women died, with 87% of the deaths occurring in lower-income countries. 1 Cervical intraepithelial neoplasia (CIN) is the premalignant stage of cervical cancer and can be classified as low grade (CIN1) and high grade (CIN2/3). 2 The gradual progression of cervical cancer allows for the application of screening programs to detect preneoplastic changes before invasive cancer develops. The Papanicolaou (Pap) test is the primary approach to cervical cancer screening. This is a screening test that allows detection of cytological abnormalities of the endocervix and ectocervix. A cervical smear is taken, which is then cytologically examined with the help of a Pap stain. 3 However, the Pap test displays a hugely variable sensitivity and specificity. Arbyn et al. 4 reported a sensitivity of 90.4% and a specificity of 64.6% of Pap cytology for detection of CIN2+, although these results are known to vary between hospitals.
Human papillomavirus (HPV) is the main causative agent of cervical cancer and so HPV DNA testing has recently been incorporated into cervical screening programs. 5 However, while the sensitivity of HPV testing exceeds that of cytology, HPV testing has not been able to match the specificity of cytology. 6 The development of an alternative to the current approaches is long overdue. Raman spectroscopy is a vibrational spectroscopic technique that has the potential to combine the diagnostic advantages of both cytology and HPV testing. Raman spectroscopy can provide a rapid, label-free, nondestructive measurement of the complete biochemical fingerprint of cells or tissues. If Raman spectroscopy can be shown to be as good as, or better than, the current gold standard, then there is great potential for the technique to be used as an alternative or an adjunct to the Pap smear test, which is available through screening programs in most developed countries. In developing countries, however, because of a lack of resources and infrastructure, screening programs are not available and a "see and treat" approach based on visual inspection using acetic acid may be more appropriate in this setting. 7 With clinical translation to lower cost, automated Raman systems, the advantages would be higher sample throughput and less requirement for highly trained cytologists and pathologists to implement the screening program.
Over the past 15 years, the potential of Raman spectroscopy together with multivariate statistical analysis has been demonstrated for the detection of a variety of cancers, including cervical cancer. [8] [9] [10] The majority of Raman spectroscopy studies on cervical cancer has focused on cervical tissue ex vivo [11] [12] [13] [14] [15] *Address all correspondence to: Fiona M. Lyng, E-mail fiona.lyng@dit.ie or in vivo, [16] [17] [18] [19] [20] with relatively few studies focusing on cervical cytology. [21] [22] [23] [24] Extensive studies have, however, been carried out on exfoliated cervical cells using infrared spectroscopy. Early studies by Wong et al. 25 showed significant differences between normal, precancer, and cancer samples but as spectra were recorded from cell pellets rather than from single exfoliated cells, a number of confounding factors, such as polymorphs, endocervical columnar cells, metaplastic cells, cervical mucus, and debris, were subsequently identified. [26] [27] [28] [29] More recent infrared studies using liquid-based cytology have shown significant spectral differences between normal, low-grade, and high-grade dysplasia. [30] [31] [32] Recent Raman spectroscopy studies showed that HPV-positive and HPV-negative cytology samples could be classified with an accuracy of 98.5% 21 and that normal and cervical cancer cytology samples could be classified with an accuracy of ∼80%. 22 Both of these studies used cell pellets rather than recording Raman spectra from single exfoliated cells and this probably resulted in the relatively low classification accuracy in the study by Rubina et al. 22 due to sample heterogeneity. Recent studies from our group have shown that Raman spectra can be successfully recorded from single exfoliated cells from liquid-based cytology Pap test specimens. 23, 24 Many of the issues involved in recording Raman spectra from cervical cytology specimens prepared according to the standard clinical protocols as single exfoliated cells on ThinPrep glass slides were addressed by Bonnier et al. 23 and a pretreatment of the slides with hydrogen peroxide to clear blood residue contamination before Raman recording was shown to minimize variability within the data sets resulting in highly reproducible data. Ramos et al. 24 reported sensitivity and specificity values of >90% for classification of negative, CIN1, CIN2, and CIN3 cervical cytology samples. Recently, Traynor et al. 33 investigated hormone-associated changes in the Raman spectra of cytologically negative ThinPrep cervical smear samples related to the menstrual cycle, the use of hormone-based contraceptives, and the onset of menopause, and showed that any spectral changes did not interfere with the ability to discriminate between normal and abnormal cervical cytology samples. This study follows on from this and focuses on defining the spectral signatures of different types of cervical exfoliated cells. Most Pap test specimens contain a variety of different cell types. These include superficial cells, intermediate cells, parabasal cells, white blood cells, endocervical cells, and squamous metaplastic cells. The most abundant of these cell types are superficial and intermediate cells, while parabasal cells are also commonly seen depending on certain factors. The ratio of superficial to intermediate cells is governed by the hormonal status of the patient, i.e., last menstrual period, use of oral contraceptive pill, or intrauterine contraceptive device. 34 As the cervix matures, the number of superficial cells tends to increase, while women taking the oral contraceptive pill tend to produce samples that contain a higher quantity of intermediate cells.
In addition, the lack of estrogenic stimulation after menopause results in the loss of cervical cell differentiation, so more parabasal cells are seen in the smear. An increase in parabasal cells is also observed when the patient is exhibiting cervical atrophy.
While the infrared and Raman spectral signatures of superficial, intermediate, and parabasal cell layers have previously been investigated in cervical tissue, 14, 15, 35, 36 to the best of our knowledge, this has not previously been investigated in single exfoliated cervical cells.
In this study, Raman spectral signatures of cervical epithelial cells-superficial, intermediate, and parabasal cells-are presented and it is shown that they can be discriminated from each other. In addition, the spectral signature of high-grade dysplastic cervical cells was compared to each of the normal cervical epithelial cell types.
Materials and Methods

Sample Collection and Preparation
Liquid-based cervical cytology samples collected in PreservCyt were obtained from the Cytopathology Department of the Coombe Women and Infants University Hospital. The study population was an anonymized group of women that had given a smear for routine screening. The cervical cells are collected by a clinician using a cervix brush or a combination of a spatula and cytobrush, before transfer of the cells into a ThinPrep vial containing a methanol-based fixative solution called PreservCyt. A total of 70 liquid-based cytology cervical samples, 20 confirmed as cytology negative, and 50 confirmed as high-grade dyskaryosis was used for this study. Ethical approval was obtained from the Research Ethics Committee of the Coombe Women and Infants University Hospital. Once routine cytological diagnosis based on the Pap test was performed, the residual material was used for this study. Cytological diagnoses are reported according to the Bethesda system, such that samples containing low-and high-grade abnormalities are classed, respectively, as low-grade squamous intraepithelial lesion (LSIL) and high-grade squamous intraepithelial lesion (HSIL). LSIL is usually indicative of CIN1, whereas HSIL is indicative of CIN2 or CIN3. 37 A further set of liquid-based cytology cervical samples, confirmed as cytology negative, was obtained from patients who had an endometrial biopsy taken on the same day as the smear test (n ¼ 10). The phase in the menstrual cycle, for each sample, could be confirmed by the corresponding endometrial biopsy. Samples from the proliferative phase (days 5 to 13) (n ¼ 4), the secretory phase (days 14 to 28) (n ¼ 4), and the interval phase (days 13 to 14) (n ¼ 2) of the menstrual cycle were available.
A monolayer of cells was prepared from the ThinPrep vial with the use of the ThinPrep processor 2000. This is an automated system that disperses the cells in the solution, collects them on the TransCyt filter, and deposits them on a ThinPrep slide. The slide was then placed in a vial containing 95% alcohol. The slides also underwent a treatment step to remove any molecular contamination by hemoglobin, which obscures several features of the cellular spectrum. 23 Briefly, slides were treated with a 30% solution of H 2 O 2 at room temperature for 3 min, followed by a 70% solution of industrial methylated spirits (IMS) for 3 min followed by multiple dips into 100% IMS to remove any remaining cellular debris and H 2 O 2 . The slide was then dried in air.
Raman Spectroscopy
A HORIBA Jobin Yvon XploRA system (Villeneuve d'Asq, France), which is coupled to an Olympus microscope BX41, was used for spectral acquisition. As a source, a 532-nm laser of ∼12-mW power was focused onto the sample using a 100× objective (MPlanN, Olympus, NA ¼ 0.9) giving a laser spot of 1 to 2 μm. The resultant Raman signals were
Journal of Biomedical Optics 105008-2 October 2017 • Vol. 22 (10) detected using a spectrograph with a 1200 g∕mm grating coupled to a charge-coupled device. Raman spectra were acquired in the fingerprint region, 400 to 1800 cm −1 , with an integration time of 30 s averaged over two accumulations. For each slide, spectra from the nucleus or cytoplasm of at least 30 cells were recorded. The x and y coordinates for each cell were recorded. A Pap stain was then performed once a satisfactory number of cells were recorded. This allowed confirmation of the cytological status of the recorded cells using the previously saved coordinates on the glass slide. Both the glass coverslip and the Pap stain interfere with Raman measurements, and so the confirmatory Pap stain could be carried out only after all Raman measurements were taken.
Data Analysis
All preprocessing and analyses were carried out using MATLAB version 7.9 (2009). Preprocessing steps involved smoothing (Savitzky-Golay k ¼ 5, w ¼ 13), baseline correction (rubber band), and vector normalization. The contribution from the glass slide was removed using a nonnegatively constrained least squares method as described in more detail in Ref. 38 . The data were then subjected to principal component analysis (PCA), an unsupervised multivariate statistical technique allowing evaluation of the variability existing in the data sets. 39 Moreover, to better appreciate the discrimination achieved by comparison of the Raman spectra, a factorial discriminant analysis (FDA) has been performed on the scores calculated from the PCA. 39 The optimal number of principal components (PCs) to generate the PCA-FDA model was found to be 10 PCs. The output of the analysis can be represented by means of a confusion matrix with all data points attributed to the groups identified by the operator (superficial, intermediate, parabasal, and HSIL cells). The statistical relevancy and robustness of the analysis have been ensured using a 100-fold cross validation, where two-thirds of the spectra have randomly been selected as the calibration set, whereas the remaining third is used as the validation set, thus over 100 independent iterations. The overall classification obtained is represented by the sensitivity and specificity. 12, 13 are more prominent in the spectra from the cytoplasm As observed previously with the spectra from the cell nuclei, glycogen features are stronger in the superficial cells as would be expected as these cells are more mature and accumulate more glycogen than the intermediate cells. 34 More prominent protein features were again observed in the spectra from the intermediate cells as these cells are metabolically active compared to the superficial cells. These findings agree well with previous studies on cervical tissue ex vivo, where the main spectral difference observed was increased glycogen features in the superficial cell layer. 14, 15 Raman spectra from the cytoplasm of the superficial cells were found to be quite variable, within individual cells and between samples. To investigate this further, an additional set of cytologically normal samples was obtained, where the phase of the menstrual cycle had been confirmed on an endometrial biopsy.
Figure 4(a) shows Raman spectra recorded from the cytoplasm of cytologically normal cervical exfoliated cells from samples taken on different days of the menstrual cycle. Only cells that were confirmed as superficial by Pap staining after Raman spectral recording were used for this analysis.
Raman spectra taken from the cytoplasm of superficial cells from the secretory phase (days 14 to 28) displayed prominent glycogen related peaks at 480, 850, 938, 1125, 1339, and 1380 cm −1 , 12,13 compared to the superficial cell spectra from the proliferative phase (days 5 to 13).
A reasonable separation of the two groups along PC1 can be seen in the PCA scatter plot [ Fig. 4(b) ]. The loadings corresponding to PC1 are shown in Fig. 4(c) with positive peaks corresponding to the superficial cells at days 14 to 28, including glycogen bands at 480, 850, 938, 1125, 1339, and 1380 cm −1 . The spectra recorded from the superficial cells at days 13 to 14 can be seen across both sides of PC1.
Similar findings were observed in an infrared spectroscopy study by Romeo et al. 40 where spectral changes in the 1200 to 1000 cm −1 region due to glycogen were reported throughout the menstrual cycle. However, a recent study from our group showed some changes in glycogen related peaks in the spectra from the nuclei of intermediate cells but no significant difference in glycogen in the spectra from the nuclei of superficial cells across the menstrual cycle. 33 As spectra were recorded from the cell nuclei in the study by Traynor et al. 33 rather than from the cytoplasm as in this study or from cell pellets as in the study by Romeo et al., 40 no significant variability due to glycogen was observed and Raman spectroscopy was shown to discriminate well between negative cytology samples taken across different days of the menstrual cycle and HSIL cytology samples. Journal of Biomedical Optics 105008-6 October 2017 • Vol. 22 (10) recorded from the cytoplasm as HSIL cells consist almost entirely of an enlarged nucleus, with very little cytoplasm (Fig. 5) . Figure 6 shows mean Raman spectra recorded from the nuclei of HSIL and normal cervical exfoliated cells. Cells were confirmed as HSIL, superficial, intermediate, or parabasal by Pap staining after Raman spectral recording. Spectral differences between the nuclei of HSIL cells and superficial, intermediate, and parabasal cells were observed at 480, 850, 938, 1125, 1339, 1450, and 1650 cm −1 .
Comparison of the
PCA was performed, where the spectra from HSIL cell nuclei were compared to the spectra from nuclei of each normal cell type. Each PCA plot and the corresponding loadings are shown in Fig. 7. Figure 7(a) shows good discrimination between superficial cells and HSIL cells along PC1. In the PCA scatter plot, the spectra of the superficial cells are on the negative side of PC1 and the spectra of the HSIL cells are on the positive side. Thus, the negative loadings of PC1 elucidate the discriminating Raman features, which can be attributed to the superficial cells, including glycogen peaks at 480, 850, 938, 1333, and 1380 cm −1 and nucleic acid peaks at 780, 1490, and 1580 cm −1
[ Fig. 7(b) ]. Fig. 7(f) ]. To further quantify the ability of Raman spectroscopy to discriminate between negative and HSIL cytology, PCA-FDA was performed using spectra from superficial, intermediate, parabasal cells, or from all cell types combined (Table 1) . Table 1 shows very good classification of both superficial and intermediate cells and HSIL cells (sensitivity of 99% and 96% and specificity of 100% and 99%, respectively). Classification of parabasal and HSIL cells is more challenging because of their morphological and biochemical similarity as noted earlier, but despite this, good sensitivity and specificity were achieved (sensitivity of 89% and specificity of 90%). Interestingly, when all negative cytology cell types were combined (superficial, intermediate, and parabasal cells), good classification of negative cytology and HSIL cytology could be achieved (sensitivity of 92% and specificity of 97%).
In previous studies on cervical exfoliated cells, similar features of glycogen (482, 852, 937, 1339, and 1380 cm −1 ) and nucleic acids (786, 1485, and 1580 cm −1 ) were reported to be more prominent in superficial and intermediate cells confirmed as cytology negative compared to HSIL cells. 22, 23 The more prominent protein features observed in the HSIL cells compared to the normal parabasal cells in this study may be reflective of a transforming HPV infection controlling the cellular machinery in the HSIL cells.
Conclusion
In this study, specific Raman spectral signatures were shown for each of the three most common cell types seen in ThinPrep liquid-based cytology samples, superficial, intermediate, and parabasal cells. Moreover, using PCA, it was shown that the spectra of each of these cell types could be differentiated from one another. Good quality Raman signals with minimal variability could be recorded from the nucleus of the normal and abnormal cells. Raman spectra recorded from the cytoplasm showed a lot more variability due to glycogen accumulations in the superficial cells and this was also found to vary depending on the phase of the menstrual cycle.
Intermediate and superficial cells are the most common cell types present on a liquid-based cytology Pap test specimen. Although it can be difficult to distinguish the two cell types morphologically on the unstained slide, they can be discriminated using Raman spectroscopy based on their biochemical signatures. In addition, both cell types can be discriminated from HSIL cells again based on their biochemical signatures. Parabasal cells are less commonly seen on most Pap test specimens and although they have a similar morphology to HSIL cells, they can be discriminated from HSIL cells based on their biochemical signature. This study has shown the potential of biochemical fingerprinting using Raman spectroscopy for cervical cancer screening using standard liquid-based cytology preparation methods.
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